Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2026-06-29 @ 1:18 PM
Study NCT ID:
NCT05795361
Status:
AVAILABLE
Last Update Posted:
2025-04-22
First Post:
2023-03-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome
Sponsor:
Takeda
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hunter Syndrome | View |
Keywords: